BURLINGTON, N.C., Sept. 24, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2024 before the market opens on Thursday, October 24, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.The call will be webcas ...

Labcorp (LH) has announced the expansion of its molecular bioanalytical laboratory in Greenfield, IN. The expanded facility will increase the company’s global molecular bioanalytical capacity, enabling the company to help biopharmaceutical customers bring life-saving advanced therapies to patients faster.The latest development is expected to positively boost the company’s Central Laboratories business under the Biopharma Laboratory Services (“BLS”) segment.Predicting LH Stock Movement Following the NewsSinc ...

The American College of Obstetricians and Gynecologists (ACOG) recommends postpartum care be treated as an ongoing process rather than a single doctor's visit. However, estimates suggest that a significant number of women do not attend even one postpartum appointment, in part due to access barriers like lack of health insurance, transportation and childcare."The postpartum period is a precarious time for women in the United States. Current standards of care provide insufficient support for women who may be ...

Labcorp Holdings Inc. (LH) recently announced the completion of its acquisition of select assets of BioReference Health — a wholly-owned subsidiary of OPKO Health, Inc. (OPK). The transaction is aimed at providing customers with greater access to Labcorp's comprehensive, high-quality laboratory services, scientific expertise and expanded testing capabilities in key regions across the United States.Likely Trend of LH Stock Following the NewsFollowing the announcement, shares of Labcorp rose 2.1% to $225.76 y ...

BURLINGTON, N.C., Sept. 16, 2024 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH) (Labcorp) announced today that its wholly owned subsidiary, Laboratory Corporation of America Holdings (LCAH), has priced its offering of $2,000,000,000 in senior notes (the Offering). The Offering consists of three tranches: $650,000,000 aggregate principal amount of 4.350% Senior Notes due 2030 (the 2030 Notes), $500,000,000 aggregate principal amount of 4.550% Senior Notes due 2032 (the 2032 Notes) and $850,000,000 aggregate ...

Enhances Labcorp's laboratory services network and expands access to its clinical services BURLINGTON, N.C. and MIAMI, Sept. 16, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today the completion of Labcorp's acquisition of select assets of BioReference Health, a wholly owned subsidiary of OPKO Health. The transaction is expected to provide ...

Labcorp Holdings, Inc. (LH) has been benefiting from the solid execution of its strategic priorities. Investments in targeted high-growth areas are expected to continue the momentum. The company faces headwinds from macroeconomic uncertainties and growing foreign exchange issues. The stock carries a Zacks Rank #3 (Hold) currently.Factors Driving LH StockAs part of its expansion efforts, Labcorp is focusing more on key growth areas such as oncology, women’s health, autoimmune disease and neurology. The compa ...

Labcorp (LH) has announced a strategic collaboration with Ballad Health to provide outreach laboratory services across the Appalachian Highlands region. Under the agreement, the company will acquire select operating assets of Ballad Health’s outreach lab services, which, combined with their ongoing partnership, aim to enhance patient care, expand access to advanced testing and improve efficiency for the health system and its patients.The companies expect to close the transaction in December 2024, subject to ...

Laboratory Corporation of America Holdings (LH) , or Labcorp, is poised for growth in the upcoming quarters due to its series of strategic acquisitions and partnerships. The company is nearing its targeted savings for the Launchpad business process improvement initiative by the end of 2024. Additionally, its strong emphasis on high-growth sectors like oncology, women’s health and neurology paves the way for substantial market gains.Meanwhile, unfavorable solvency and the adverse impacts of macroeconomic cha ...

Labcorp (LH) has been benefiting from the solid execution of its strategic priorities. Investment in targeted high-growth areas should continue to drive the momentum. The company faces headwinds from macroeconomic uncertainties and currency translations. The stock carries a Zacks Rank #3 (Hold) currently.As part of its expansion efforts, Labcorp is focusing more on key growth areas such as oncology, women’s health, autoimmune disease and neurology. The company’s ability to develop, license and ultimately sc ...